These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34801660)

  • 1. Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery.
    Melamed JR; Hajj KA; Chaudhary N; Strelkova D; Arral ML; Pardi N; Alameh MG; Miller JB; Farbiak L; Siegwart DJ; Weissman D; Whitehead KA
    J Control Release; 2022 Jan; 341():206-214. PubMed ID: 34801660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs.
    LoPresti ST; Arral ML; Chaudhary N; Whitehead KA
    J Control Release; 2022 May; 345():819-831. PubMed ID: 35346768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice.
    Andries O; Mc Cafferty S; De Smedt SC; Weiss R; Sanders NN; Kitada T
    J Control Release; 2015 Nov; 217():337-44. PubMed ID: 26342664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.
    Kauffman KJ; Mir FF; Jhunjhunwala S; Kaczmarek JC; Hurtado JE; Yang JH; Webber MJ; Kowalski PS; Heartlein MW; DeRosa F; Anderson DG
    Biomaterials; 2016 Dec; 109():78-87. PubMed ID: 27680591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mixing method used to formulate lipid nanoparticles affects mRNA delivery efficacy and organ tropism.
    Strelkova Petersen DM; Chaudhary N; Arral ML; Weiss RM; Whitehead KA
    Eur J Pharm Biopharm; 2023 Nov; 192():126-135. PubMed ID: 37838143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in mRNA vaccines.
    Li M; Wang Z; Xie C; Xia X
    Int Rev Cell Mol Biol; 2022; 372():295-316. PubMed ID: 36064266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs.
    Kauffman KJ; Dorkin JR; Yang JH; Heartlein MW; DeRosa F; Mir FF; Fenton OS; Anderson DG
    Nano Lett; 2015 Nov; 15(11):7300-6. PubMed ID: 26469188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
    Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
    Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing
    Hajj KA; Melamed JR; Chaudhary N; Lamson NG; Ball RL; Yerneni SS; Whitehead KA
    Nano Lett; 2020 Jul; 20(7):5167-5175. PubMed ID: 32496069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system.
    Bernard MC; Bazin E; Petiot N; Lemdani K; Commandeur S; Verdelet C; Margot S; Perkov V; Ripoll M; Garinot M; Ruiz S; Boudet F; Rokbi B; Haensler J
    Mol Ther Nucleic Acids; 2023 Jun; 32():794-806. PubMed ID: 37346973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency.
    Forster Iii J; Nandi D; Kulkarni A
    Biomater Sci; 2022 Sep; 10(19):5566-5582. PubMed ID: 35971974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
    Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
    J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells.
    Patel SK; Billingsley MM; Frazee C; Han X; Swingle KL; Qin J; Alameh MG; Wang K; Weissman D; Mitchell MJ
    J Control Release; 2022 Jul; 347():521-532. PubMed ID: 35569584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer.
    Melamed JR; Yerneni SS; Arral ML; LoPresti ST; Chaudhary N; Sehrawat A; Muramatsu H; Alameh MG; Pardi N; Weissman D; Gittes GK; Whitehead KA
    Sci Adv; 2023 Jan; 9(4):eade1444. PubMed ID: 36706177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Branched-Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pH.
    Hajj KA; Ball RL; Deluty SB; Singh SR; Strelkova D; Knapp CM; Whitehead KA
    Small; 2019 Feb; 15(6):e1805097. PubMed ID: 30637934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.
    Han X; Alameh MG; Butowska K; Knox JJ; Lundgreen K; Ghattas M; Gong N; Xue L; Xu Y; Lavertu M; Bates P; Xu J; Nie G; Zhong Y; Weissman D; Mitchell MJ
    Nat Nanotechnol; 2023 Sep; 18(9):1105-1114. PubMed ID: 37365276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.